Additionally, the phosphorylation levels of AKT and PI3K in pancreatic cancer cells overexpressing CCNI2 were increased, and treatment with a PI3K inhibitor partially reversed this effect. The gene discussed is PIK3CA; the disease is pancreatic neoplasm.